paclitaxel has been researched along with Vascular Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Garvey, DS; Janero, DR; Letts, LG; Lin, CE; Marek, P; Richardson, SK; Serebryanik, D; Shumway, MJ; Tam, SW; Trocha, AM; Young, DV | 1 |
| Chen, Y; Fu, G; Ge, J; He, B; He, Y; Ji, F; Jin, H; Li, C; Li, L; Liu, F; Ma, G; Nie, S; Qian, J; Sun, Y; Wang, H; Wang, J; Wei, M; Wu, Y; Xia, Y; Xu, B; Yin, J; Zeng, H | 1 |
| Alfonso, F; Cortese, B; Erriquez, A; Rivero, F; Testa, G | 1 |
| Rissanen, TT | 1 |
| Karmota, AG | 1 |
| Hatta, K; Maruoka, R; Nakamura, K; Ohmichi, M; Ono, YJ; Tanabe, A; Terai, Y; Watanabe, A | 1 |
| Peters, D; Scheller, B; Speck, U; Stolzenburg, N | 1 |
| Chun, KR; De Potter, TJ; Kuck, KH; Malisius, R; Nuyens, D; Ouyang, F; Schmidt, B; Schneider, C | 1 |
| Biedermann, M; Clever, YP; Cremers, B; Kelsch, B; Mahnkopf, D; Schaffner, S; Scheller, B; Speck, U | 1 |
| Alberola, V; Albert, A; Campos, JM; Caranyana, V; Juan, O; Muñoz, J | 1 |
| Creel, CJ; Edelman, ER; Lovich, MA | 1 |
| Axel, DI; Baumbach, A; Blattner, A; Heinle, H; Herdeg, C; Karsch, KR; Oberhoff, M; Schröder, S | 1 |
1 review(s) available for paclitaxel and Vascular Diseases
| Article | Year |
|---|---|
How does a drug-coated balloon work? Overview of coating techniques and their impact.
Topics: Angioplasty, Balloon; Animals; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Drug Delivery Systems; Drug-Eluting Stents; Endovascular Procedures; Equipment Design; Excipients; In Vitro Techniques; Materials Testing; Models, Animal; Paclitaxel; Surface Properties; Swine; Vascular Diseases | 2016 |
4 trial(s) available for paclitaxel and Vascular Diseases
| Article | Year |
|---|---|
Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Humans; Paclitaxel; Prospective Studies; Treatment Outcome; Vascular Diseases | 2023 |
Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.
Topics: Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Risk Factors; Treatment Outcome; Vascular Diseases | 2023 |
Paclitaxel coated-balloon (PCB) versus standard plain old balloon (POB) fistuloplasty for failing dialysis access.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Coated Materials, Biocompatible; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Renal Dialysis; Vascular Access Devices; Vascular Diseases | 2020 |
Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Comorbidity; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heart Diseases; Humans; Lung Neoplasms; Male; Multivariate Analysis; Paclitaxel; Patient Compliance; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vascular Diseases | 2007 |
7 other study(ies) available for paclitaxel and Vascular Diseases
| Article | Year |
|---|---|
Combination of paclitaxel and nitric oxide as a novel treatment for the reduction of restenosis.
Topics: Adamantane; Animals; Antineoplastic Agents; Constriction, Pathologic; Iliac Artery; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Paclitaxel; Platelet Aggregation Inhibitors; Rabbits; Recurrence; Stents; Vascular Diseases | 2004 |
Paclitaxel-coated balloons are safe for the treatment of arterial stenoses.
Topics: Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Femoral Artery; Humans; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Treatment Outcome; Vascular Diseases | 2023 |
Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.
Topics: Adult; Aged; Antineoplastic Agents; Bezafibrate; Carboplatin; Endothelium, Vascular; Female; Genital Neoplasms, Female; Humans; Middle Aged; Nitric Oxide; Paclitaxel; Pilot Projects; PPAR alpha; Triglycerides; Umbilical Veins; Vascular Diseases; Vasodilator Agents | 2015 |
Drug-eluting stents for the treatment of pulmonary vein stenosis after atrial fibrillation ablation.
Topics: Adult; Aged; Atrial Fibrillation; Catheter Ablation; Constriction, Pathologic; Drug-Eluting Stents; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Paclitaxel; Pulmonary Veins; Retrospective Studies; Secondary Prevention; Sirolimus; Treatment Outcome; Vascular Diseases | 2011 |
Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model.
Topics: Angioplasty, Balloon, Coronary; Animals; Catheters; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Male; Paclitaxel; Swine; Vascular Diseases | 2011 |
Arterial paclitaxel distribution and deposition.
Topics: Angiogenesis Inhibitors; Animals; Biological Transport; Carotid Arteries; Cattle; Drug Delivery Systems; Paclitaxel; Vascular Diseases | 2000 |
Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Constriction, Pathologic; Paclitaxel; Rabbits; Recurrence; Swine; Vascular Diseases | 2000 |